Sharda Cropchem reported weak numbers for Q2 with the margins down to 16.1 percent. In an interview to CNBC-TV18, RV Bubna, CMD of Sharda Cropchem discussed more on the company's performance.
Sharda Cropchem posted a subdued set of earnings in Q1 as margins continue to remain volatile with a 400 bps fall this quarter.
In an interview to CNBC-TV18, RV Bubna, CMD of Sharda Cropchem spoke about the latest happenings in his company and sector.
In an interview with CNBC-TV18, RV Bubna, CMD of Sharda Cropchem said that the cmpany is comfortable with the current level of growth in margins and expects to see growth in its European business.
RV Bubna, Chairman and Managing Director, Sharda Cropchem is confident of a 15-20 percent CAGR growth over the next three years assuming constant currency and stable conditions.
Sharda Cropchem Chairman and Managing Director tells CNBC-TV18 that EU contributed over 55% of sales.
RV Bubna, chairman and managing director of Sharda Cropchem, expects the company to grow 15-20 percent in volume terms in FY17.
RV Bubna, CMD, Sharda CropChem says this fall was on the back of controlled sales in Latin America, Mexico, Cananda and South Africa due to excessive currency devaluation.
In an interview with CNBC-TV18, Chairman and MD of Sharda Cropchem, RV Bubna said that if the fluctuation in Euro-dollar continues, it could impact the company‘s topline growth adversely.
In an interview with CNBC-TV18's Reema Tendulkar, RV Bubna, Chairman and Managing Director, Sharda Cropchem, discussed his company's fourth quarter earnings.
In an interview to CNBC-TV18, RV Bubna, CMD, Sharda Cropchem shares his business outlook and expectations from the company going ahead.